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Abstract – In this work, we propose a multi-parametric 
in vitro study of the cytotoxicity of gold nanoparticles 
(GNPs) on human endothelial cell (HUVEC). The 
cytotoxicity is evaluated by incubating cells with six 
different GNP types which have two different 
morphologies: spherical and flower-shaped, two sizes 
(ý15 and ý50 nm diameter) and two surface chemistries 
(as prepared form and PEGylated form). Our results 
showed that by increasing the concentration of GNPs 
the cell viability decreases with a toxic concentration 
threshold of 10 pM for spherical GNPs and of 1 pM for 
flower-shaped GNPs. Dark field images, flow cytometry 
and spreading test revealed that flower-shaped GNPs 
have more deleterious effects on the cell mechanisms 
than spherical GNPs. We demonstrated that the main 
parameter in the evaluation of the GNPs toxicity is the 
GNPs roughness and that this effect is independent on 
the surface chemistry. We assume that this behavior is 
highly related to the efficiency of the GNPs 
internalization within the cells and that this effect is 
enhanced due to the specific geometry of the flower-
shaped GNPs. 
 
Index terms - Microscopy, Nano medicine,  Optical 
Imaging. 
 
I. INTRODUCTION 
 
Gold nanoparticles (GNPs) are of great interest for several 
applications in nanomedicine, especially in imaging and 
sensing [1], drug delivery [2, 3] and photothermal therapy 
[4, 5] because of their unique physical and chemical 
properties, and high biocompatibility.  
Among different morphologies of GNPs, gold 
nanospheres (GNSs) are widely used for biomedical 
applications [6, 7]. In recent years, gold nano flowers 
(GNFs) (also termed as urchin like, branched particles or 
stars) have been proposed to improve the light–matter 
interaction and thus the optical properties of such 
nanostructures which is essential for photothermal 
therapeutics 8, 9] or optical cellular imaging [10–12]; 
thanks to their tips which are responsible to a higher local 
electromagnetic field enhancement [13].  
For all these applications, a better understanding of the 
interaction and uptake of GNPs into cells is of great 
importance and currently under intense investigation [14–
17], especially for GNFs who exhibit improved optical 
properties. In this latter case, it is then of first importance 
to determine if this higher efficiency is suitable with an 
acceptable biocompatibility. variable in their interaction 
with cells [18–20]. Chithrani et al reported the effect of 
GNP size on the cellular uptake with sizes varying 
between 14 and 100 nm [21]. GNPs larger than 10 nm in 
diameter internalized inside cells were trapped in vesicles 
in the cytoplasm and did not enter in the nucleus [18, 21].  
Pan et al suggested that the uptake of GNPs is mediated 
by non-specific adsorption of proteins onto the gold 
surface, which induces internalization into cells via the 
endocytosis mechanism [19, 20]. 
Many reported works showed that GNPs size and 
aggregation can affect cell adhesion and proliferation: Cui 
et al showed that small GNSs (2 nm), which are more 
stable against aggregation, caused less HeLa cytotoxicity 
than larger GNSs (25 nm) which are liable to form 
aggregates [22]. Arvizo et al studied the effect of GNP 
size on inhibition of endothelial and fibroblast cell 
proliferation. It was demonstrated that 20 nm GNSs 
showed a maximal inhibition of cell proliferation up to 
100% whereas 10 nm showed up to 60% and 5 nm up to 
25% of inhibition [23]. In the same way, Pernodet et al 
reported that 14 nm GNSs had a significant uptake into 
dermal fibroblasts [24]. It was suggested that the presence 
of GNPs is responsible for abnormal actin filaments and 
extracellular matrix constructs in dermal fibroblasts; 
which decrease cell proliferation, adhesion, and motility. 
Jiang et al proposed that GNPs can not only passively 
interact with cells, but also at a specific size actively alter 
the molecular processes that are essential for regulating 
the cell functions [25]. GNPs of 40–50 nm are found to be 
the optimal sizes for receptor-mediated endocytosis. This 
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higher particle uptake is probably due to the direct 
balance between multivalent cross linking of membrane 
receptors and the process of membrane wrapping 
involved in receptor-mediated endocytosis. 
Nanoparticle size is not the only relevant parameter in the 
GNPs–cell interaction. The cell membrane seems to be 
also very sensitive to the GNP’s surface chemistry. By 
considering only the surface chemistry, Goodman et al 
found that cationic particles are moderately toxic, whereas 
anionic particles are rather less toxic [18, 26]. Freese et al 
have discussed different polymer coatings and concluded 
that the positive-charge coated GNPs were internalized to 
a greater extent than the negative- or neutral-charged 
GNPs, as would be expected due to interactions with the 
anionic cell membrane [27]. Arnida et al showed that 
GNPs appeared to be taken up by nonspecific adsorptive 
endocytosis [28]. PEGylation (PEG=poly ethylene glycol) 
on the surface of GNPs drastically reduced this uptake.  
In this study, we have employed such approach to 
evaluate the cellular uptake and cytotoxicity of GNPs in 
adherent human endothelial cells (HUVEC). Our study 
includes in total six different types of GNPs which have 
two morphologies: spherical (ý15 and ý50 nm diameter 
termed as: 15-a-GNS and 50-a-GNS) and flower-shaped 
(only ý50 nm diameter termed as: a-GNF); and two 
surface chemistries- as prepared form and after polymer 
stabilization by polyethylene glycol which were termed 
as: 15-PEG-GNP, 50- PEG-GNP, PEG-GNF. 
 
II. MATERIALS AND METHODS 
 
II.1. Synthesis and surface modification of GNPs 
GNFs were prepared by the rapid mixture of 20 mL 
solution of 19.8 × 10f3M of ascorbic acid with 200 l of 
10f2M of HAuCl4 at ice temperature [12]. Colloidal 
GNSs of 15 nm were synthesized by the aqueous 
reduction of HAuCl4 with trisodium citrate according to 
the Turkevich–Frens method. 
One batch of each type of GNPs was modified using 
mPEG-SH polymer of 5 kDa molecular weight, that 
provided more stability to the particles. Depending on the 
nanoparticle type and hence on its surface area, various 
amounts of 10f3M polymeric solution were added to the 
colloidal solution by dripping. The polymer-nanoparticle 
mixtures were subjected to vigorous stirring after which 
let to sit for 24 h at 4 °C to afford a complete binding of 
the polymer. Both as-prepared and polymer stabilized 
GNPs (a-GNPs and PEG-GNPs, respectively) were 
purified by centrifugation at high speed and resuspended 
in ultrapure water until the incubation with cells. 
 
II.2. Cell culture 
Human vascular endothelial cells (HUVEC, N CRL-1730, 
ATCC, LGC Molsheim, France) were cultured in 
endothelial cell basal media 2 (ECBM2, PromoCell, 
Germany) supplemented with 10% fetal bovine serum, 
epidermal growth factor (EGF, 5.0 ng mLf1), 
hydrocortisone (0.2 gmLf1), VEGF (0.5 ng mLf1), basic 
fibroblast factor (bFF, 10 ng mLf1), insulin like growth 
factor (R3IGF-1, 20 ng mLf1), ascorbic acid (1 gmLf1), 
heparin (22.5 gmLf1), antibiotics (penicillin- 
streptomycin, 1, Invitrogen, France) and L-glutamine (1, 
Invitrogen, France) at 37 °C. in 5% CO2.  
 
III. RESULTS & DISCUSSION 
 
Figure 1 illustrates the results of cell morphology, actin 
cytoskeleton structure and histograms of measured cell 
surface area of blank and treated cells with GNPs. In 
control condition (figure 1(A)) of non-treated HUVEC, 
fluorescence microscopy images showed F-actin fibers 
(with rhodaminelabeled phalloidin) in whole cell body 
and in adhesion focal contacts. The cells had well spread 
form showing cell-to-cell or cell-to-extracellular matrix 
focal adhesion complex (FAC). F-actin fibers had 
continuous thread-like structure which seemed nicely 
distributed along the cell body giving to the endothelial 
cell an appropriate regular morphology (not deform, not 
compact cell shape, well spread shape). 
In the case of treated cells with GNSs, coexistence of both 
deformed and few spread cells with healthy structure are 
observed (figures 1(B1) and (C1)); whereas, treated cells 
with GNFs showed more deformed and compact cells 
with a highly concentrated actin fibers in cell peripheries 
(figure 1(D1)). In general, we observe that F-actin 
cytoskeleton of all GNPs treated cells has been alternated 
compared to blank, well spread cells showing the stress 
fibers formation. 
After 3 h incubation with GNPs, the cell surface areas 
were measured for 100 cells from both GNPs treated and 
nontreated (blank) cells and represented as histograms to 
elaborate quantitatively the extent of changes in cell 
morphology. Thus it fully represents the stress caused by 
the presence of GNPs. The mean cell surface area of 50-
PEG-GNSs treated cells is around 540 m2 whereas for 
50-a-GNSs, the cell surface area is about 420 m2 (figure 
1(B2)). In the case of 15-PEGGNSs, the mean surface 
area of treated cells was around 440 m2, while for 15-a-
GNSs it was close to 340 m2 (figure 1(C2)). GNFs 
exhibited a prominent shape effect on the cell surface area 
(figure 1(D2)).  For both surface chemistries the surface 
area was reduced to 350 m2 for PEGGNFs and to 260 
m2 for a-GNFs. Therefore, comparing to control (650 
m2), the loss in cell surface area was in order of a-GNFs 
(60%) > 15-a-GNSs (48%) > 50-a-GNSs (35%).  
This observation can also be done for all PEG-GNPs such 
as the loss in cell surface is estimated to be PEG-GNFs 
(46%) > 15- PEG-GNSs (32%) > 50-PEG-GNSs (17%). 
Thus, a decrease of the surface area of the cells is 
observed for all the GNPs and all surface chemistry. This 
indicate that whatever the GNPs used, the cells are 
stressed even if this effect is reduced by the used of 
PEGylated surface chemistry and by the use of 50-GNS.  
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Furthermore, we observe the same hierarchical 
organization of the effects as for previous experiments 
(cell viability) meaning the highest effect for the a-GNF 
and the lowest one for the 50-PEG-GNS. 
 
Figure 1: Fluorescence images of HUVEC incubated with 0.5 
pM of GNPs for 3 h (A: blank, B1: 50-a-GNS, C1: 15-a-GNS 
and D1: GNF) (scale bar: 7 m). Nuclei are labeled with DAPI 
(blue) and actin cytoskeleton with Alexa Fluor 546-phalloidin 
(orange-red). Histograms represent the cell surface areas of 
control cells (gray) and cells incubated with (B2) 50-GNS, (C2) 
15-GNS and (D2) GNF. In histograms, black and striped bars 
demonstrate consecutively as prepared and PEG surface 
chemistries of the GNPs. Moreover, $ denotes average cell area 
of cells in blank, * and Ë denote the average surface area of as 
prepared and PEG-GNPs treated cells respectively. 
 
IV. CONCLUSION 
 
In this work, we demonstrate that the cytotoxicity of the 
GNPs depends on the size and the shape of the GNPs as 
well as on the surface chemistry. Increasing concentration 
of nanoparticles decreased cell viability; and thus we 
determined the threshold toxic concentration of around 
100 pM, 10 pM and 0.5 pM consecutively for 50-a- 
GNSs, 15-a-GNSs and a-GNFs. Flow cytometry analysis 
demonstrated the more deleterious effect of GNFs over 
GNSs. We noticed more affinity of GNFs on HUVEC 
than 15-GNSs, where 50-GNSs had the least affinity. We 
were able to compare the degree of cytotoxic effect and 
demonstrated that it is largely higher for GNFs than for 
GNSs. Even if we showed an enhanced biocompatibility 
of the GNSs due to the PEG coating, we demonstrated 
that the surface chemistry has no effect for the GNFs. 
This latter point indicates that the main parameter in the 
evaluation of the GNPs toxicity is the GNPs roughness. 
Thus, even if the GNFs have optical properties that imply 
a better efficiency in application as photothermal therapy, 
they could have more deleterious effects on the biological 
media.  
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